FXR agonism protects against liver injury in a rat model of intestinal failure-associated liver disease
Journal Title: Journal of Clinical and Translational Research - Year 2017, Vol 3, Issue 3
Abstract
Background: Intestinal failure-associated liver disease (IFALD) is a clinical challenge. The pathophysiology is multifactorial and remains poorly understood. Disturbed recirculation of bile salts, e.g. due to loss of bile via an enterocutaneous fistula, is considered a major contributing factor. We hypothesize that impaired signaling via the bile salt receptor FXR underlies the development of IFALD. The aim of this study was to investigate whether activation of FXR improves liver homeostasis during chronic loss of bile in rats. Methods: To study consequences of chronic loss of bile, rats underwent external biliary drainage (EBD) or sham surgery for seven days, and the prophylactic potential of the FXR agonist INT-747 was assessed. Results: EBD for 7 days resulted in liver test abnormalities and histological liver damage. Expression of the intestinal FXR target gene Fgf15 was undetectable after EBD, and this was accompanied by an anticipated increase in hepatic Cyp7a1 expression, indicating increased bile salt synthesis. Treatment with INT-747 improved serum biochemistry, reduced loss of bile fluid in drained rats and prevented development of drainage-associated histological liver injury. Conclusions: EBD results in extensive hepatobiliary injury and cholestasis. These data suggest that FXR activation might be a novel therapy in preventing liver dysfunction in patients with intestinal failure. Relevance for patients: This study demonstrates that chronic loss of bile causes liver injury in rats. Abrogated recycling of bile salts impairing of enterohepatic bile salt/FXR signaling underlies these pathological changes, as administration of FXR agonist INT747 prevents biliary drainage-induced liver damage. Pharmacological activation of FXR might be a therapeutic strategy to treat disorders accompanied by a perturbed enterohepatic circulation such as intestinal failure-associated liver disease.
Authors and Affiliations
Kiran V. K. Koelfat, Ruben G. J. Visschers, Caroline M. J. M. Hodin, D. Rudi de Waart, Wim G. van Gemert, Jack P. M. Cleutjens, Marion J. Gijbels, Ronit Shiri-Sverdlov5, Rajeshwar P. Mookerjee6, Kaatje Lenaerts, Frank G. Schaap, Steven W. M. Olde Damink
Immune mechanisms of idiosyncratic drug-induced liver injury
Idiosyncratic drug reactions (IDRs) continue to be an important issue. Specifically, idiosyncratic drug-induced liver injury (IDILI) is the most likely IDR to lead to drug withdrawal, and it accounts for a significant po...
Modified protrusive wax record in recording condylar path angle and ethnic variations
Background: The Condylar Path Angle (CPA) is an important measurement that is used to program articulators used in dental treatment. The purpose of the current study was to investigate the CPA in Malay subjects, to compa...
Layer-by-layer heparinization of decellularized liver matrices to reduce thrombogenicity of tissue engineered grafts
Background: Tissue–engineered liver grafts may offer a viable alternative to orthotopic liver transplantation and help overcome the donor organ shortage. Decellularized liver matrices (DLM) have a preserved vasculature a...
Evidence against a role for platelet-derived molecules in liver regeneration after partial hepatectomy in humans
Background and Aim: Blood platelets have been shown to stimulate liver regeneration after partial hepatectomy in animal models and humans, but the molecular mechanisms involved are unclear. It has been proposed that grow...
Higher blood pressure and lower cardiac vagal activity in obese young individuals in supine and seated position
Background: Obesity triggers alterations in hemodynamic and autonomic control. There are few studies that investigate the effects of overweight and obesity in early adulthood on hemodynamic and autonomic variables. Aim:...